EIP
OCUL icon

Essential Investment Partners’s Ocular Therapeutix OCUL Stock Holding History

Essential Investment Partners’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.9K Hold
9,155
– – 0.07% 127
2026
Q1 		$77.5K Hold
9,155
– – 0.07% 124
2025
Q4 		$111K Buy
+9,155
New +$111K 0.1% 100

Other funds holding OCUL

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

Essential Investment Partners's OCUL Position: Q2 2026 in Review

Essential Investment Partners held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 9,155 shares worth $89.9K. The position accounts for 0.07% of the portfolio, ranked #127.

Essential Investment Partners first reported a position in OCUL in Q4 2025 and has held it in 3 quarters since. The position peaked at $111K in Q4 2025. 32 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Essential Investment Partners held 9,155 shares of Ocular Therapeutix worth $89.9K as of Q2 2026.
  • Essential Investment Partners left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up 0.07% of Essential Investment Partners's portfolio in Q2 2026, its #127 holding.
  • Essential Investment Partners first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 3 quarters since.
  • Essential Investment Partners's Ocular Therapeutix position peaked at $111K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Essential Investment Partners's 13F filing for Q2 2026, filed 15 Jul 2026.